- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 79 results
In the News · Source: JUVE
November 22, 2022
King & Spalding represents Novartis in landmark pharma reboxing case before ECJ
Cases & Deals
November 17, 2022
King & Spalding represents Novartis on landmark ECJ pharma packaging victory
Recognition
November 4, 2022
JUVE Handbook 2022/23 Recognizes Multiple King & Spalding Practices, Individuals
In the News · Source: JUVE
October 13, 2022
Real estate counsel Moritz Heidbuechel joins the firm’s Corporate, Finance and Investments practice group in Frankfurt
In the News · Source: JUVE
September 20, 2022
Tax counsel Martin Wolff joins the firm’s Corporate, Finance and Investments practice group in Frankfurt
Press Release
September 1, 2022
King & Spalding Recruits Five-Lawyer Frankfurt Corporate Team Led by Partner Peter Memminger
In the News · Source: Law360, Law360 UK, The Global Legal Post, Legal Business, The Deal and Law.com International
September 1, 2022
K&S adds a five-lawyer corporate and private equity team, led by partner Peter Memminger, to its Corporate, Finance & Investments practice group in Frankfurt
In the News · Source: JUVE
Cases & Deals
August 10, 2022
King & Spalding Advises on Financing for Circular Resources' Recycling Acquisitions
In the News · Source: Immobilien Zeitung, The Global Legal Post and Legal Era
June 30, 2022
Axel Schilder is appointed the new managing partner of the firm's Frankfurt office
Recognition
June 23, 2022
Best Lawyers Recognizes International King & Spalding Lawyers in its 2023 Guides